The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis

Journal of Neuroimmunology

Volumn 178, Issue 1-2, 2006, Pages 161-166

  Thangarajh, Mathula ^a,b   Masterman, Thomas ^a   Helgeland, Lars ^c   Rot, Uroš ^d   Jonsson, Malin V ^b   Eide, Geir Egil ^c   Pirskanen, Ritva ^e   Hillert, Jan ^a   Jonsson, Roland ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

APRIL; B cell survival factors; BAFF; Myasthenia gravis; Thymus

Indexed keywords

APRIL PROTEIN; TUMOR NECROSIS FACTOR;

ARTICLE; B LYMPHOCYTE; BIOACCUMULATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MALE; MYASTHENIA GRAVIS; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE; THYMUS; THYMUS HYPERPLASIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; B-LYMPHOCYTES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MIDDLE AGED; MYASTHENIA GRAVIS; PROTEOGLYCANS; RECEPTORS, TUMOR NECROSIS FACTOR; SYNDECAN-1; SYNDECANS; THYMUS GLAND; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748283337     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.05.023     Document Type: Article

References (20)

1. Colombara M., Antonini V., Riviera A.P., Mainiero F., Strippoli R., Merola M., Fracasso G., Poffe O., Brutti N., Tridente G., Colombatti M., and Ramarli D. Constitutive activation of p38 and ERK1/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. J. Immunol. 175 (2005) 7021-7028
2. Do R.K., Hatada E., Lee H., Tourigny M.R., Hilbert D., and Chen-Kiang S. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192 (2000) 953-964
3. Drachman D.B. Myasthenia gravis. N. Engl. J. Med. 330 (1984) 1797-1810
4. Gorelik L., Gilbride K., Dobles M., Kallad S.L., Zandman D., and Scott M.L. Normal B cell homeostasis requires B cell activation factor production by radiation resistant cells. J. Exp. Med. 198 (2003) 937-945
5. Gorelik L., Cutler A.H., Thill G., Miklasz S.D., Shea D.E., Ambrose C., Bixler S.A., Su L., Scott M.L., and Kalled S.L. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J. Immunol. 172 (2004) 762-766
6. Hase H., Kanno Y., Kojima M., Hasegawa K., Sakurai D., Kojima H., Tsuchiya N., Tokunaga K., Masawa N., Azuma M., Okumura K., and Kobata T. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 103 (2004) 2257-2265
7. He B., Chadburn A., Jou E., Schattner E.J., Knowles D.M., and Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J. Immunol. 172 (2004) 3268-3279
8. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., Qiang F., Gorelik L., Kalled S.L., Acha-Orbea H., Rennert P.D., Tschopp J., and Schneider P. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201 (2005) 1375-1383
9. Kao I., and Drachman D.B. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science 195 (1977) 74-75
10. Levinson A.I., Zweiman B., Lisak R.P., Dziarski A., and Moskovitz A.R. Thymic B-cell activation in myasthenia gravis. Neurology 34 (1984) 462-468
11. Mackay F., and Browning J.L. BAFF: a fundamental survival factor for B cells. Nat. Rev., Immunol. 2 (2002) 465-475
12. Melms A., Schalke B.C., Kirchner T., Muller-Hermelink H.K., Albert E., and Wekerle H. Thymus in myasthenia gravis. Isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest. 81 (1988) 902-908
13. Ng L.G., Sutherland A.P., Newton R., Qian F., Cachero T.G., Scott M.L., Thompson J.S., Wheway J., Chtanova T., Groom J., Sutton I.J., Xin C., Tangye S.G., Kalled S.L., Mackay F., and Mackay C.R. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J. Immunol. 173 (2004) 807-817
14. Novak A.J., Bram R.J., Kay N.E., and Jelinek D.F. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood 100 (2002) 2973-2979
15. Schneider P., Mackay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., Ambrose C., Lawton P., Bixler S., Acha-Orbea H., Valmori D., Romero P., Werner-Favre C., Zubler R.H., Browning J.L., and Tschopp J. BAFF, a novel ligand of the tumornecrosis factor family, stimulates B cell growth. J. Exp. Med. 189 (1999) 1747-1756
16. Shiono H., Fujii Y., Okumura M., Takeuchi Y., Inoue M., and Matsuda H. Failure to down-regulate Bcl-2 protein in thymic germinal center B cells in myasthenia gravis. Eur. J. Immunol. 27 (1997) 805-809
17. Shiono H., Roxanis I., Zhang W., Sims G.P., Meager A., Jacobson L.W., Liu J.L., Mathews I., Wong Y.L., Bonifati M., Micklem K., Stott D.I., Todd J.A., Beeson D., Vincent A., and Willcox N. Scenarios for autoimmunization of T and B cells in myasthenia gravis. Ann. N.Y. Acad. Sci. 998 (2003) 237-256
18. Thien M., Phan T.G., Gardam S., Amesbury M., Basten A., Mackay F., and Brink R. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20 (2004) 785-798
19. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., Hession C., Schneider P., Sizing I.D., Mullen C., Strauch K., Zafari M., Benjamin C.D., Tschopp J., Browning J.L., and Ambrose C. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293 (2001) 2108-2111
20. Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat. Rev., Immunol. 2 (2002) 797-804